Xanthopterin is a synthetic pteridine derivative investigated as an antiparkinsonian agent that enhances dopamine activity for the treatment of Parkinson's disease. Within analytical and pharmaceutical… Read more
Xanthopterin is a synthetic pteridine derivative investigated as an antiparkinsonian agent that enhances dopamine activity for the treatment of Parkinson's disease. Within analytical and pharmaceutical laboratories, this compound and its related derivatives are essential for rigorous quality control and method validation. This category provides access to high-quality reference standards, including synthesis-related impurities and stable isotope-labelled compounds, which are vital for researchers conducting precise quantitative analysis. By utilizing these materials, scientists can perform accurate impurity profiling and metabolic studies using techniques such as high-performance liquid chromatography (HPLC). These research-grade tools ensure the reliability and reproducibility of analytical data throughout the pharmaceutical development lifecycle, allowing for the consistent identification and quantification of the parent drug and its associated byproducts in complex matrices.